Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes.

Authors:
Address: International Center for Excellence in Malaria Research in West Africa at the Medical Research Council Laboratories, Fajara, Gambia.
Journal:

Publication:

abstract

The study sites for the West African ICEMR are in three countries (The Gambia, Senegal, Mali) and are located within 750 km of each other. In addition, the National malaria control Programmes of these countries have virtually identical policies: (1) Artemisinin Combination Therapies (ACTs) for the treatment of symptomatic Plasmodium falciparum infection, (2) Long-Lasting Insecticide-treated bed Nets (LLINs) to reduce the Entomololgic Inoculation Rate (EIR), and (3) sulfadoxine-pyrimethamine for the Intermittent Preventive Treatment of malaria during pregnancy (IPTp). However, the prevalence of P. falciparum malaria and the status of malaria control vary markedly across the four sites with differences in the duration of the transmission season (from 4-5 to 10-11 months), the intensity of transmission (with EIRs from unmeasurably low to 4-5 per person per month), multiplicity of infection (from a mean of 1.0 to means of 2-5) and the status of malaria control (from areas which have virtually no control to areas that are at the threshold of malaria elimination). The most important priority is the need to obtain comparable data on the population-based prevalence, incidence and transmission of malaria before new candidate interventions or combinations of interventions are introduced for malaria control.

Related Articles
Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa.
Am J Trop Med Hyg. 1999
Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa.
Beier JC, Killeen GF, Githure JI. Am J Trop Med Hyg. 1999 Jul; 61(1):109-13.
Review Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Am J Trop Med Hyg. 2004
Review Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG, Alilio MS, Mills A. Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):1-15.
Review Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Drug Saf. 2007
Review Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Peters PJ, Thigpen MC, Parise ME, Newman RD. Drug Saf. 2007; 30(6):481-501.
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.
PLoS Med. 2008
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.
Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC. PLoS Med. 2008 Nov 25; 5(11):e226; discussion e226.
Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uganda.
Trans R Soc Trop Med Hyg. 2011
Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uganda.
Ndyomugyenyi R, Clarke SE, Hutchison CL, Hansen KS, Magnussen P. Trans R Soc Trop Med Hyg. 2011 Nov; 105(11):607-16. Epub 2011 Oct 2.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.